Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Children’s Hospital of Philadelphia activated as new center for ZEVASKYN gene therapy for rare skin disease.

Market News
11 May 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Abeona Therapeutics has activated the Children’s Hospital of Philadelphia (CHOP) as the sixth Qualified Treatment Center for ZEVASKYN, a gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), a rare and severe skin disorder. This expansion improves access to the treatment on the U.S. East Coast, allowing more patients to benefit from this innovative therapy that promotes wound healing and pain reduction. CHOP’s involvement highlights its leadership in pediatric care and gene therapy. Patients can contact CHOP or Abeona Assist for treatment and support services.

More News (ABEO)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App